LASAK, LLC
CZECH REPUBLIC, XX

Company profile LASAK focuses on the development, manufacture and sale of innovative healthcare products, particularly bone and dental implants and bone regeneration materials. The company was founded 1991 by doc. Ing. Zdeněk Strnad, CSc. and Ing. Igor Riedl, CSc. In addition to its production activities, the company systematically pursues its own research and development programs in co-operation with leading scientific institutions, universities and prestigious clinics throughout the Czech Republic, focusing above all on the development of new biomaterials. Particular attention is paid to bioactive materials with a basis of calcium phosphate ceramics, bioactive glass ceramics and bioactive titanium materials. LASAK produces several types of advanced ceramic bioactive materials, under the brands In 1993, LASAK began producing a new innovative system of In 2000 the LASAK BIO-surface was the first hydrophilic bioactive surface of titanium implants on the market and this concept of surface treatment was soon adopted by leading world manufacturers and is now used all over the world. LASAK was awarded the prestigious Czech Scientific Award, “Ceska Hlava 2010” Based on twenty years of experience and following the latest trends in implantology, LASAK launched a new system of dental implants Company profile LASAK focuses on the development, manufacture and sale of innovative healthcare products, particularly bone and dental implants and bone regeneration materials. The company was founded 1991 by doc. Ing. Zdeněk Strnad, CSc. and Ing. Igor Riedl, CSc. In addition to its production activities, the company systematically pursues its own research and development programs in co-operation with leading scientific institutions, universities and prestigious clinics throughout the Czech Republic, focusing above all on the development of new biomaterials. Particular attention is paid to bioactive materials with a basis of calcium phosphate ceramics, bioactive glass ceramics and bioactive titanium materials. LASAK produces several types of advanced ceramic bioactive materials, under the brands In 1993, LASAK began producing a new innovative system of In 2000 the LASAK BIO-surface was the first hydrophilic bioactive surface of titanium implants on the market and this concept of surface treatment was soon adopted by leading world manufacturers and is now used all over the world. LASAK was awarded the prestigious Czech Scientific Award, “Ceska Hlava 2010” Based on twenty years of experience and following the latest trends in implantology, LASAK launched a new system of dental implants LASAK company founded by doc. Ing. Zdenek Strnad, CSc,. and Ing. Igor Riedl, CSc. The establishment of the LASAK company was preceded by cooperation in research and development at the Sklo Union Research Institute, as well as cooperation with a number of Czech and foreign institutions, in the field of researching new materials for artificial tissue and organ replacements. After the closure of the Sklo Union Research Institute, at the beginning of the 1990s, doc. Ing. Zdenek Strnad, CSc., together with Ing. Igor Riedl, CSc., motivated by previous successful research, decided to create a new centre where it would be possible to continue researching these advanced materials. Towards the end of 1991, they founded the LASAK company with its headquarters in Prague, where not only research, but also the realization of these promising materials was successfully achieved. The first implant system of the LASAK company, IMPLADENT, was launched on the market. The IMPLADENT implant system is gradually being recognized worldwide, with all technical details complying with the international consensus on material and design requirements for osseointegrated implants, i.e. implants inserted in the bone without any soft tissue interlayer, which can be considered a fundamental feature of contemporary dental implantology. At the time of its launch, dental implants were sandblasted and coated with bioactive hydroxyapatite. This type of surface was characterized by high osseoconduction properties and extreme tolerance of unfavourable conditions of osseointegration. Since 2000, after lauching LASAK´s new unique, hydrophilic, nanostructured, bioactive surface (BIO-surface), IMPLADENT implants are treated with this surface, thus significantly enhancing their properties. In the same year, LASAK also launched synthetic replacements for bone tissue based on glass ceramics and ceramics. Since these fully synthetic materials did not contain any organic elements, there was zero risk of immune reactions or transmission of pathogens. Maximum effort and intensive investment in regular research and development facilitated the creation and introduction of a new bone graft product, PORESORB-TCP. It is a fully synthetic, tricalcium-phosphate-based material for bone regeneration. Thanks to its macro- and microporous characteristics, the structure of PORESORB-TCP is very similar to bone structure. As a bioactive, resorbable, inorganic, crystalline, non-metallic bone regeneration material, PORESORB-TCP has gained a good reputation, not only in dental implantology but also in neurosurgery and orthopaedics. The LASAK company was one of the first implant manufacturers to produce narrow-diameter implants with a diameter of only 2.9 mm. By 2006, as the first implant manufacturer on the European market, the company was already able to present a nine-year clinical study with excellent results. The product portfolio was widened with intervertebral disc replacements The excellent osseoconductive properties of new titanium materials, that lead to faster and improved healing of IMPLADENT dental implants, made it possible to extend the application of these materials into neurosurgery. In addition to dental implants, LASAK started producing intervertebral disc replacements, which prevent instability of the affected motion segment of the lumbar or cervical spine. The successful development of a breakthrough technology of titanium surface treatment. LASAK was the first company to launch a bioactive, hydrophilic, nanostructured surface treatment of dental implants (BIO-surface) on the European market.